Cytori awarded NIH Grant to develop cell-based treatments for vascular disease
Cytori Therapeutics was awarded a $250,000 NIH (National Institutes of Health) Grant to develop adipose-derived regenerative cells as a treatment for vascular disease.
Regenerative cells within adipose (fat) tissue include adult stem cells and other cell types that have been shown to increase blood flow in and around damaged and oxygen deprived tissues. As a result, these cells hold exciting potential for the treatment of vascular conditions such as peripheral arterial disease, atherosclerosis, and critical limb ischemia, which impact millions of patients each year worldwide.
Most read news
Organizations
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.